Urolog. pro Praxi, 2009; 10(4): 238-243

Urinary incontinence from a gynaecologist’s perspective

MUDr. Petr Dzvinčuk Ph.D, MUDr. Otakar Müller, MUDr. Eva Látalová
Porodnicko-gynekologická klinika FN a LF UP Olomouc

The urinary incontinence belongs to the most frequent health problems in female population. Approximately 50 % of women suffer from

any type of incontinence during their lifetime. This condition is not associated with high morbidity or mortality, however it influences the

quality of life of affected patient. The aim of this article is to provide brief review of current diagnostical and therapeutical approach and

methods in management of urinary incontinence.

Keywords: female urinary incontinence, stress urinary incontinence, urgent incontinence, urodynamics, pharmacotherapy, surgical therapy.

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dzvinčuk P, Müller O, Látalová E. Urinary incontinence from a gynaecologist’s perspective. Urol. praxi. 2009;10(4):238-243.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the International Continence Society. Neurol Urodyn 2002; 21: 167-178. Go to original source... Go to PubMed...
    2. Dmochowski RR, Miklos JR, Norton PA, et al. Duloxetine versus placebo for treatment of North American women with stress urinary incontinence. J Urol 2003; 170: 1259-1263. Go to original source... Go to PubMed...
    3. Enhoering G. A concept of urinary continence. Urol int 1976; 3: 31. Go to original source... Go to PubMed...
    4. Hanuš T. Epidemiologie inkontinence moči. Urol List 2004; 1: 14-18.
    5. Hanuš T. Standardizovaná terminologie. Praha: StudiaGeo, 1998: 34.
    6. Kolombo I, Kolombová J, Porš J, et al. Stresová inkontinence u žen - 1. část. Urolog. pro Praxi, 2008; 9(6): 292-300.
    7. Kolombo I, Kolombová J, Porš J, et al. Stresová inkontinence u žen - 2. část. Urolog. pro Praxi, 2009; 10(1): 11-20.
    8. Krhut J, Kopecký J. Využití aplikace botulinumtoxinu do detruzoru u pacientek s refrakterním hyperaktivním měchýřem. Čes Gynek 2007; 72(6): 402-406.
    9. Krhut J, Holaňová R, Muroňová I, Gärtner M. Výsledky konzervativní nefarmakologické terapie u pacientek s močovou inkontinencí. Čes Gynek 2007; 72(6): 406-409.
    10. Martan A. Inkontinence moči u žen a její medikamentózní léčba. Praha: Maxdorf, 2006: 36-37.
    11. Martan A. Inkontinence moči u žen a její medikamentózní léčba. Praha: Maxdorf 2006; 48-68.
    12. Martan A. Nové možnosti v medikamentózní léčbě stresové inkontinence moči u žen. Čes Gynek 2004, 69(6): 500-506.
    13. Tanagho EA, Meyers FH, Smith DR. Urethral resistence: Its components and implications. I. Smooth muscle component. Invest Urol 1969; 7: 136-149. Go to PubMed...
    14. Ulmsten U, Hendriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anaesthesia for treatment of female urinary incontinence. Int. Urogynecol J 1996; 7: 81-86. Go to original source... Go to PubMed...
    15. Verner P. Farmakoterapie močové inkontinence. Farmakoterapie 2007; 3(5): 513-522.
    16. Ward KL, Hilton P, UK and Ireland TVT Trial Group. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol 2004; 190: 324-331. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.